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Objectives.We compared an early registry of rotational atherec-
tomy with a recent registry to examine the evolution of patient
profiles, lesion characteristics and procedural outcomes for pa-
tients treated with rotational atherectomy.
Background. With increased experience, the selection of pa-
tients and lesions treated with a device matures. This study
documents the changes in the application of rotational atherec-
tomy.
Methods. The patient characteristics and procedural outcomes
from two multicenter patient registries—Registry I: 2,953 proce-
dures, 3,717 lesions from 1988 to 1993; and Registry II: 200
procedures, 268 lesions from 1994—were analyzed and compared.
Results. There was an increase in the average age of the
patients (63 vs. 65 years, p < 0.02) and the proportion of patients
with unstable angina (42.9% vs. 56.5%, p < 0.01) or previous
coronary artery bypass graft surgery (18.8% vs. 24.5%, p < 0.05)
in Registry II. Registry II included fewer left anterior descending
coronary lesions (46.5% vs. 32.8%, p < 0.01), more type B and C
lesions (83.1% vs. 91.8%, p < 0.01), more eccentric lesions (69.0%
vs. 79.5%, p < 0.01) and more calcified lesions (50.3% vs. 69.4%,
p < 0.01). Complications, including urgent bypass surgery, Q and
non–Q wave myocardial infarction, dissection, acute occlusion
and perforation, were similar in the two groups. However, mor-
tality increased from 1.0% to 3.0% (p < 0.05) in Registry II.
Conclusions. Comparison of recent and early patients treated
with rotational atherectomy revealed an increase in the complex-
ity of patients and lesions. Although the rate of death was
increased, the overall rate of major complications was not signif-
icantly changed (4.7% vs. 6.0%, p 5 NS).
(J Am Coll Cardiol 1997;29:353–7)
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As a procedure or device progresses from an investigational
device to a device routinely used by trained operators, the
indications for use, procedure results and incidence of compli-
cations may evolve as well. Registries of percutaneous balloon
angioplasty over time have revealed significant changes in
patient selection, procedural success and complications (1,2).
Use in practice will reflect both published information and
individual operator experience. Since 1986 several devices for
percutaneous revascularization have made the transition from
investigational to approved devices.
Rotational atherectomy, first introduced in 1988 and ap-
proved for general use in 1993, was evaluated in a multicenter
registry at 22 sites whose independent operators collected
information on patient selection and procedural success during
that period. In 1994, a second registry at eight sites collected
similar information. The aim of this study was to assess the
differences, if any, in patient profile, clinical success and
incidence of complications after treatment with rotational
atherectomy in these two groups.
Methods
From 1988 to 1993, data from 2,953 procedures (3,717
lesions) treated with rotational atherectomy were collected in
a multicenter registry at 22 sites. The original 743 procedures
with 874 lesions were analyzed and were the subject of a
previous report (3). We compared the data from the entire
multicenter registry of 2,953 procedures (Registry I) to a new
registry collected in 1994 (Registry II), which includes 200
procedures in 268 lesions. Registry II was collected to evaluate
minor changes in the device, specifically the removal of the
Teflon coating on the distal end of the drive shaft. In this latest
series, data were collected from eight sites; seven of the eight
sites had participated in the original registry. These seven sites
contributed 71% (2,100 of 2,953) of the cases in Registry I and
78% (156 of 200) of the cases in Registry II.
Inclusion and exclusion criteria for the two registries were
similar and have been presented previously (3). In summary,
patients with a coronary lesion .70% in a native coronary
artery, lesion length ,25 mm and without recent acute myo-
cardial infarction or angiographic evidence of thrombus were
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eligible. All patients gave written informed consent approved
by their institution.
Procedure. For Registry I, the technique of rotational
atherectomy was described previously (3). Premedication in-
cluded aspirin and a calcium channel blocking agent. Heparin
was given to maintain an activated clotting time .300 s, and
nitroglycerin was given by topical, intravenous or intracoronary
routes at the discretion of the operator. All patients had
venous access with a 6 to 8F femoral conduit and arterial
access with an 8 to 10F sheath. Commercially available 8 to 10F
guide catheters were used. The lesion was crossed with a
0.009-in. (0.023-cm) guide wire (type A or C, Boston Scientific
Northwest Technology Center, formerly Heart Technology),
and the Rotablator was advanced to the site and activated at
180,000 to 200,000 rpm. After high speed rotational atherec-
tomy with one or more burrs, adjunctive balloon angioplasty
was performed at the operator’s discretion.
After the procedure, patients were heparinized for 16 to
24 h and continued to receive aspirin and calcium channel
blockers. Patients were discharged at the discretion of the
physician, with no specific medical regimen dictated by the
protocol.
Definitions. Procedural success was defined as residual
stenosis ,50% and the absence of complications, including
death, emergency coronary artery bypass graft surgery
(CABG) and Q wave myocardial infarction (MI). The inci-
dence of non–Q wave MI was examined but was not included
in procedural success. The exact definition of non–Q wave MI
evolved with time and was redefined in a stringent manner as
an increase in creatine kinase (CK) greater than two times
normal with a positive myocardial band. However, in about
half of the cases it was not possible to retrospectively analyze
for the new non–Q wave definition because of the lack of CK
data.
Statistics. Chi-square analysis using the Yates correction
or, in comparisons where fewer than five cases were expected,
the Fisher exact method was used to determine significance
(p , 0.05) for binary and categoric variables. The continuous
variables were compared using an unpaired t test. The denom-
inators for the demographics and lesion characteristics vary
owing to incomplete reporting. These differences were not
thought to be systematic. Statistical significance was accepted
at p # 0.05.
Results
Patient characteristics. Several significant changes oc-
curred in the patient group over time (Table 1). Registry II
included older patients (65 vs. 63 years, p , 0.02), a higher
proportion of patients with previous CABG (24.5% vs. 18.8%,
p , 0.01) and more patients with unstable angina (56.5% vs.
42.9%, p , 0.01).
Lesion characteristics. The differences in lesion site
treated and lesion characteristics are shown in Table 2. There
was a decrease in the number of left anterior descending
coronary artery (LAD) lesions treated, from 46.5% in Registry
I to 32.8% in Registry II (p , 0.01). There was a concomitant
increase in right coronary artery (RCA) and left circumflex
coronary artery (LCx) lesions. Treatment of lesions in the left
main coronary artery trunk remained unchanged.
Abbreviations and Acronyms
AHA/ACC 5 American Heart Association/American College of
Cardiology
CABG 5 coronary artery bypass graft surgery
CK 5 creatine kinase
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
RCA 5 right coronary artery
Table 1. Patient Characteristics
Registry I
1988–93
Registry II
1994
Age (yr) 63 6 11* 65 6 12
Male 71.4 68.5
Previous MI 40.5 42.5
Diabetic 23.2 26.5
Hypertension 55.8 58.5
Hypercholesterolemia 64.8 60.0
Previous CABG 18.8* 24.5
Multivessel disease 65.4 68.0
Unstable angina 42.9† 56.5
*p , 0.05. †p , 0.01. Data shown are mean value 6 SD or percent of
patients. CABG 5 coronary artery bypass graft surgery; MI 5 myocardial
infarction.
Table 2. Lesion Characteristics
Registry I
1988–93
Registry II
1994
No. of lesions 3,717 268
No. of procedures 2,953 200
No. of lesions treated/procedure 1.26* 1.34
Location
LAD 46.5%* 32.8%
RCA 29.7%* 37.3%
LCx 19.3%† 26.5%
LMCA 3.3% 3.4%
AHA/ACC lesion type
A 17.0%† 8.2%
B 66.2%† 74.6%
C 16.9%† 17.2%
Restenotic 29.1% 32.8%
Length .10 mm 24.7% 27.6%
Eccentric 69.0%† 79.5%
Calcified 50.3%† 69.4%
Bifurcation 28.5% 26.9%
Ostial 22.7% 17.9%
*p, 0.025. †p, 0.01. AHA/ACC5 American Heart Association/American
College of Cardiology; LAD 5 left anterior descending coronary artery; LCx 5
left circumflex coronary artery; LMCA5 left main coronary artery; RCA5 right
coronary artery.
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Similarly, the number of lesions treated per procedure
increased from 1.26 in Registry I to 1.34 in Registry II (p ,
0.025). In addition, lesion characteristics associated with rota-
tional atherectomy became more complex; American Heart
Association/American College of Cardiology (AHA/ACC)
type A lesions accounted for 17% of lesions in Registry I and
8.2% of lesions in Registry II. In Registry II, AHA/ACC type
B and C lesions accounted for .90% of the lesions. The
proportion of lesions that were eccentric (69% in Registry I vs.
79.5% in Registry II, p , 0.01) or calcified (50.3% in Registry
I vs. 69.4% in Registry II, p , 0.01) also increased. The
proportion of bifurcational lesions, ostial lesions, lesions
.10 mm in length and restenotic lesions remained unchanged.
Major complications. The incidence of major complica-
tions after rotational atherectomy is shown in Table 3. The
incidence of death increased from 1% to 3% (p , 0.025).
When comparing the two registries, no other complication
occurred with increased frequency. It is important to note that
the incidence of non–Q wave MI is not directly comparable
because the definition of this complication changed with time
and data were incomplete.
Procedural success, defined as ,50% residual stenosis in
the absence of death, Q wave MI or emergency CABG, was
compared for lesion type and lesion location. Despite the
increase in lesion complexity, there was no significant change
in procedural success in the more recent experience compared
with the earlier data, as shown in Table 4. In Registry I, type A
and B lesions were treated with greater success than type C
lesions. Lesions located in the LCx were treated with greater
success than RCA or LAD lesions, but these differences were
small and may not be clinically relevant. In Registry II, which
had fewer cases, there were no detectable differences in
procedural success by lesion location or type.
Angiographic complications. The incidences of four angio-
graphic complications are shown in Table 5. None are signifi-
cantly changed from Registry I to Registry II.
Discussion
Extrapolating from Registry II, rotational atherectomy is
being performed in more complex lesion subsets, with a greater
number of lesions being treated per procedure in older pa-
tients with more unstable angina and previous CABG. This
trend is more apparent when compared with the initial 743
procedures previously published (3). This early report included
27% type A lesions (vs. ,10%), 1.18 lesions/procedure (vs.
1.34) and 40% calcified lesions (vs. 69%).
Lesion complexity. The increase in lesion complexity ob-
served in this study is based on operator report rather than on
evaluation by a core angiographic laboratory. A large percent-
age of cases originated in centers participating in both regis-
tries, promoting consistency of observer interrogation between
the two registries. In addition, an independent core laboratory
documented lesion characteristics from a random sample of
500 patients treated between 1988 and April 1992 (4), which
were consistent with the interpretation of the operators.
In a substudy, when the cases from the seven centers
participating in both registries were compared, several obser-
vations were apparent. First, these high volume centers had a
higher percentage of complex patients in the initial registry
(Table 6), and, second, patient complexity at these sites increased
further from Registry I to Registry II. An unexpected obser-
vation was that the proportion of patients experiencing a CK
elevation .300 U/liter was greater in the centers with lower
enrollment and fewer complex patients. Whether this differ-
ence in CK elevation represents a learning curve or is a result
of the lesion, patient and operator characteristics is uncertain.
Table 3. Complications
Registry I
Event/Procedure (%)
Registry II
Event/Procedure (%)
Death 29/2,953 (1.0%)* 6/200 (3.0%)
CABG 74/2,953 (2.5%) 5/200 (2.5%)
Q wave MI 34/2,953 (1.2%) 1/200 (0.5%)
Non–Q Wave MI† 179/2,953 (6.1%) 12/200 (6.0%)
*p, 0.025. †Definitions vary and are not directly comparable. Abbreviations
as in Table 1.
Table 4. Procedural Success* by Lesion
Registry I Registry II
AHA/ACC lesion type
A 484/504 (96.0%) 21/22 (95.4%)
B 1,880/1,968 (95.5%) 192/200 (96.0%)
C 451/501 (90.0%) 43/46 (93.5%)
Lesion location
LAD 1,618/1,727 (93.7%) 82/88 (93.2%)
RCA 1,041/1,105 (94.2%) 99/100 (99.0%)
LCx 735/761 (96.6%) 66/71 (92.9%)
LMCA 118/124 (95.2%) 9/9 (100%)
Primary 2,340/2,500 (93.6%) 172/180 (95.5%)
Restenotic 991/1,024 (96.8%) 84/88 (95.4%)
,10 mm long 2,515/2,650 (94.9%) 177/186 (95.2%)
11 to 25 mm long 811/871 (93.1%) 66/69 (95.6%)
*Procedural success was considered ,50% residual stenosis in the absence
of death, coronary artery bypass graft surgery or Q wave myocardial infarction.
There were no significant differences between registries; type A and B lesions are
more successfully treated (p , 0.001) than type C lesions in the larger registry.
The left circumflex coronary artery is more successfully treated than the left
anterior descending coronary artery or right coronary artery (p , 0.025) in the
larger registry. No significant differences were demonstrated within the smaller
registry. Abbreviations as in Table 2.
Table 5. Angiographic Complications
Registry I
Event/Lesion
(%)
Registry II
Event/Lesion
(%)
Dissection 405/3,717 (11.0%) 31/268 (11.6%)
Acute occlusion 152/3,717 (4.1%) 9/268 (3.4%)
Postprocedure abrupt closure 34/2,953 (1.2%) 2/200 (1.0%)
Perforation 23/3,717 (0.6%) 1/268 (0.4%)
There were no significant differences between the two registries.
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Procedural success. Even though these older patients had
more unstable angina, more calcified lesions and fewer AHA/
ACC type A lesions, there was no significant change in
procedural success. There was, however, an increase in mor-
tality, which remains puzzling and is certainly a stimulus for
reflection. Although the cause of this increase is unclear, it may
reflect increased lesion and patient complexity. For example, a
subset analysis of rotational atherectomy in calcified lesions (5)
demonstrated a slightly higher death rate (1.2% vs. 0.5% in
calcified vs. noncalcified lesions, respectively, p, 0.04). In that
analysis, calcified lesions included a higher proportion of other
angiographic risk factors, with 57% having two or more risk
factors, compared with 46.5% for noncalcified lesions (p ,
0.001). Although the mortality rate in the current registry is
higher than that seen in routine angioplasty data sets (6,7), it is
similar to the 2.7% mortality rate reported for “high risk”
angioplasty (8). Similarly, in a report of angioplasty in patients
with a reduced ejection fraction (#40%), the death rate
climbed to 2.6% (9).
The description of the patient group currently treated with
rotational atherectomy reflects characteristics similar to those
observed by Stertzer et al. (10)—with older patients, a rela-
tively high incidence of diabetes (31% vs. 15% with percuta-
neous transluminal coronary angioplasty [PTCA]), previous
CABG (31% vs. 19% with PTCA) and restenotic lesions (33%
vs. 13% with PTCA). The percentage of calcified (43.1% vs.
69.4%) and eccentric (55.6% vs. 79.5%) lesions appears to be
higher for patients in the 1994 registry than that for patients
treated by rotational atherectomy reported by Stertzer et al.
(10), whereas overall lesion complexity appears to be similar
with type A lesions, accounting for 10% of the lesions treated.
The distribution of lesions within the coronary tree was also
similar to that observed by Stertzer et al. (10).
Previous studies of rotational atherectomy. Several reports
of single-center experiences with rotational atherectomy have
been published (11–16). For the most part, these data were
collected before May 1993, when the Rotablator was not
approved for commercial distribution in the United States, and
thus represent analyses of data collected into the original
multicenter registry. Several recent reports include a substan-
tial number of procedures that are not part of the original
multicenter registry (17–19). In a single-center, randomized
trial of rotational atherectomy versus excimer laser versus
PTCA in type B2 and C lesions (17), procedural success was
93% with rotational atherectomy compared with 83% with
PTCA, and major cardiac events, including death, emergency
CABG and Q wave MI, were lower with rotational atherec-
tomy (1.5%) than with PTCA (7.0%). Similarly, according to
single-center data on 159 patients with type B2 and C lesions,
the major cardiac event rate was 2.5%, with another 5.7%
suffering from non–Q wave MI (18). This study excluded
29.4% of patients treated with rotational atherectomy at this
institution who had type A or B1 lesions. Finally, a report on
710 procedures (19) from late 1990 to 1994 includes 2 years of
data after the original multicenter registry. In this report the
rate of major cardiac events was 3.7%, with type A and B1
lesions representing 25% and type C lesions 46% of the lesions
treated. The rate of major cardiac events in Registry II (6.0%)
is higher than that reported in these studies, even though they
also included more severe lesions.
Technique changes. Registry II incorporated a few of the
recent advances in rotational atherectomy technique (20),
including attempting to monitor and control the deceleration
of the atherectomy burr to ,5,000 rpm from its platform
speed. The role of the guide wire in directing the cutting vector
of the burr and the impact of guide wire bias on complications
(21) had not been identified. In addition, although some
centers have begun to use a perfusion cocktail to decrease
spasm and slow flow (19,22), it was not in routine use for this
registry. The importance of heat generation (23) and platelet
activation due to device deceleration (24) had not been
delineated. The role of technique modifications in procedural
success and restenosis will await the outcome of the random-
ized trials in progress.
Study limitations. There are several limitations to the
present study. The data from the more recent registry repre-
sent data collected after minor changes in Rotablator design.
Although such changes should not affect patient selection, they
may impact outcomes. Second, the occurrence of some vari-
ables, specifically complications, are infrequent enough that a
sample of 200 is not large enough to ensure accurate and
reliable sampling. Third, the lesion characteristics are based on
operator report rather than on core laboratory analysis, as
discussed earlier. Finally, centers participating in these regis-
tries are institutions with high-volume operators performing
numerous procedures, and thus their outcomes may not reflect
a more generalized practice.
Conclusions. Rotational atherectomy is being applied to
complex lesions, with a significant increase in calcified and
Table 6. Comparison Between Nonoverlapping Sites and
Overlapping Sites of Registries I and II Including Only
Characteristics That Were Different Between the Nonoverlapping
and Overlapping Sites of Registry I
Sites Participating
Only in Registry I*
Sites Participating in
Both Registries
Registry I† Registry II‡
Patient characteristics
Age (yr) (mean 6 SD) 61 6 11 64 6 11 65 6 11
Hypercholesterolemia 58.3 67.2 79
Previous CABG 14.0 20.7 28
Multivessel disease 52.6 68.1 73.0
Lesion characteristics
Type A 33.3 12.6 7.0
Type B 58.3 68.3 72.4
Type C 8.4 19.1 20.5
Eccentric 52.9 70.3 77.0
Calcified 32.1 54.0 68.0
Outcomes§
% CK . 300 U/liter 25.5 10.9 10.2
*Twelve sites, 853 procedures. †Seven sites, 2,100 procedures. ‡Seven sites,
156 procedures. §Other complications were not different between the two
groups. CABG 5 coronary artery bypass graft surgery; CK 5 creatine kinase.
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eccentric morphologies. The patients treated with rotational
atherectomy represent an older group with a high incidence of
diabetes, multivessel disease and unstable angina. The increas-
ing lesion and patient complexity, without a decrease in
procedural success, suggests that rotational atherectomy may
allow percutaneous treatment of patients who were previously
considered poor candidates for intervention. The increased
mortality in the recent registry is a concern and may reflect the
increased procedural complexity or relatively rare quantum
events in a small sample size, especially in light of the low
complication rates of other studies with complex lesions
(18,19). Ongoing randomized studies should clarify these
issues, which include important technique modifications.
The technique of rotational atherectomy has evolved from
a procedure performed under strict protocol to a widely used
procedure in mainstream percutaneous interventions. Since its
introduction in 1988, it has established itself as a technique
with high procedural success, despite increasingly complex
patient subsets with more difficult anatomy, particularly calci-
fied lesions, for whom it has become the technique of choice.
Appendix
Investigational Centers and Principal Investigators
Registry I: A complete list of the participants in Registry I appears in
reference 3.
Registry II: Maurcie Buchbinder, MD,* Scripps Memorial Hospital, San
Diego, California; Ted Feldman, MD, University of Chicago Hospital, Chicago,
Illinois; Martin Leon, MD,* Washington Hospital Center, Washington, D.C.;
Robert Kipperman, MD,* Galichia Medical Group, Wichita, Kansas; Simon
Stertzer, MD,* Stanford University, Palo Alto, California; Gerald Dorros, MD,*
University of Wisconsin, Milwaukee, Wisconsin; Patrick Whitlow, MD,* Cleveland
Clinic, Cleveland, Ohio; David Warth, MD,* Providence Medical Center, Seattle,
Washington.
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